Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants

被引：0
|
作者：
Draelos, Zoe [1 ]
Tanghetti, Emil [2 ]
Gold, Linda Stein [3 ]
Kircik, Leon [4 ]
Bhatia, Neal [5 ]
Zeichner, Joshua [4 ]
Sugarman, Jeffrey [6 ]
机构：
[1] Dermatol Consulting Serv PLLC, High Point, NC USA
[2] Ctr Dermatol & Laser Surg, High Point, NC USA
[3] Henry Ford Hosp, Detroit, MI USA
[4] Icahn Sch Med Mt Sinai, New York, NY USA
[5] Therapeut Clin Res, New York, NY USA
[6] Univ Calif San Francisco, San Francisco, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43390
引用
收藏
页码：AB33 / AB33
页数：1
相关论文
共 50 条
  • [1] Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials
    Draelos, Zoe D.
    Tanghetti, Emil A.
    Kircik, Leon H.
    Bhatia, Neal
    Zeichner, Joshua A.
    Sugarman, Jeffrey L.
    Gold, Linda Stein
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [2] Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
    Linda Stein Gold
    Hilary Baldwin
    Leon H. Kircik
    Jonathan S. Weiss
    David M. Pariser
    Valerie Callender
    Edward Lain
    Michael Gold
    Kenneth Beer
    Zoe Draelos
    Neil Sadick
    Radhakrishnan Pillai
    Varsha Bhatt
    Emil A. Tanghetti
    American Journal of Clinical Dermatology, 2022, 23 : 93 - 104
  • [3] Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug
    Stein Gold, Linda
    Baldwin, Hilary
    Kircik, Leon H.
    Weiss, Jonathan S.
    Pariser, David M.
    Callender, Valerie
    Lain, Edward
    Gold, Michael
    Beer, Kenneth
    Draelos, Zoe
    Sadick, Neil
    Pillai, Radhakrishnan
    Bhatt, Varsha
    Tanghetti, Emil A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (01) : 93 - 104
  • [4] Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
    Harper, Julie C.
    Kircik, Leon
    Gold, Michael
    Hebert, Adelaide A.
    Sugarman, Jeffrey L.
    Green, Lawrence
    Gold, Linda Stein
    Baldwin, Hilary
    Guenin, Eric
    Del Rosso, James
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (03) : 125 - 131
  • [5] Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysis
    Callender, Valerie D.
    Baldwin, Hilary
    Gold, Linda Stein
    Cook-Bolden, Fran E.
    Guenin, Eric
    Alexis, Andrew F.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
  • [6] Impact of Age or Sex on Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel in Participants with Moderate-to-Severe Acne
    Gold, Linda Stein
    Kircik, Leon
    Werschler, William
    Baldwin, Hilary
    Callender, Valerie
    Green, Lawrence
    Sadick, Neil
    Sugarman, Jeffrey
    Draelos, Zoe
    Tanghetti, Emil
    Bhatia, Neal
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB54 - AB54
  • [7] Efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: Randomized phase 2 and phase 3 studies of the first triple-combination drug
    Gold, Linda Stein
    Kircik, Leon H.
    Tanghetti, Emil A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50
  • [8] Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study
    Eichenfield, Lawrence F.
    Gold, Linda Stein
    Kircik, Leon H.
    Werschler, William P.
    Beer, Kenneth
    Draelos, Zoe D.
    Tanghetti, Emil A.
    Papp, Kim A.
    Baldwin, Hilary
    Lain, Edward
    Sadick, Neil
    Gooderham, Melinda J.
    Konda, Adarsh
    PEDIATRIC DERMATOLOGY, 2023, 40 (03) : 452 - 459
  • [9] Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey
    Baldwin, Hilary
    Harper, Julie C.
    Zeichner, Joshua A.
    Draelos, Zoe D.
    Eichenfield, Lawrence E.
    Gold, Michael
    Gold, Linda Stein
    Kircik, Leon
    JOURNAL OF DRUGS IN DERMATOLOGY, 2024, 23 (11) : 1017 - 1024
  • [10] Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
    Kircik, Leon H.
    Stein Gold, Linda
    Gold, Michael
    Weiss, Jonathan S.
    Harper, Julie C.
    Del Rosso, James Q.
    Bunick, Christopher G.
    Bhatia, Neal
    Tanghetti, Emil A.
    Eichenfield, Lawrence F.
    Baldwin, Hilary
    Draelos, Zoe D.
    Callender, Valerie D.
    Han, George
    Gooderham, Melinda J.
    Sadick, Neil
    Lupo, Mary P.
    Lain, Edward
    Werschler, William Philip
    DERMATOLOGY AND THERAPY, 2024, 14 (05) : 1211 - 1227
12345